Development and Pharmacokinetics of Galactosylated Poly-L-Glutamic Acid as a Biodegradable Carrier for Liver-Specific Drug Delivery
- 1 January 1996
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 13 (6) , 880-884
- https://doi.org/10.1023/a:1016053128569
Abstract
Purpose. A biodegradable carrier for the liver-specific delivery of drugs was developed using poly-L-glutamic acid (PLGA) modified with galactose (galactosylated PLGA or Gal-PLGA), and its...Keywords
This publication has 14 references indexed in Scilit:
- Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugsCritical Reviews in Oncology/Hematology, 1995
- Design for Cell-Specific Targeting of Proteins Utilizing Sugar-Recognition Mechanism: Effect of Molecular Weight of Proteins on Targeting EfficiencyPharmaceutical Research, 1995
- Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives.1992
- Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusionBiochemical and Biophysical Research Communications, 1992
- A NEW RADIOCHEMICAL METHOD TO DETERMINE THE STABILITY-CONSTANTS OF METAL-CHELATES ATTACHED TO A PROTEIN1990
- Disposition and Tumor Localization of Mitomycin C–Dextran Conjugates in MicePharmaceutical Research, 1987
- Antitumor agent poly (amino acid) conjugates as a drug carrier in cancer chemotherapy.Journal of Pharmacobio-Dynamics, 1984
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981
- Glomerular permselectivity: barrier function based on discrimination of molecular size and chargeAmerican Journal of Physiology-Renal Physiology, 1978
- Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1971